AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.
- AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.
- The CDMO provides recombinant proteins, vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics.
- Dr. Haifer stated "These senior executive appointments are key to shaping the company as we move forward with our growth plans.
- AcuraBio will immediately benefit from Guillaume Herry's experience with companies in the US, Europe and Australia designing and implementing growth strategies.